SRPT•benzinga•
Wells Fargo Initiates Coverage On Sarepta Therapeutics with Overweight Rating, Announces Price Target of $115
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 11, 2025 by benzinga